Muscle protein abundant in the heart plays key role in blood clotting during heart attack The surprise finding from a Scripps Research team reveals a potential new approach for treating cardiovascular diseases.
April 02, 2020
LA JOLLA, CA A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot worsening damage to heart tissue, a new study shows.
A team led by John H. Griffin, PhD, a professor in the Department of Molecular Medicine at Scripps Research, made the unexpected finding after a series of experiments spanning three years and involving researchers from multiple collaborating institutions.
Though blood clotting is the root cause of many life-threatening cardiac events, including heart attack and stroke, scientists didn't know until now that cardiac myosin was implicated in that process. The protein's primary job is to provide the muscle-motor action that pumps blood.
The real breakthrough of this study is that we've discovered another major biologic activity of cardiac myosin. No one had suspected it was acting as a procoagulant factor, Griffin says. Our findings bridge research in hematology and cardiology, showing there's another potentially very important factor influencing the health outcomes of people with cardiac disease.
Blood coagulation is essential to prevent bleeding after an injury. The most abundant procoagulant protein in the human body is collagen, but it's not usually exposed to blood. Upon blood vessel and tissue damage, many procoagulant factors, including collagens, cause blood to turn from a liquid into a gel, forming a blood clot and reducing blood loss. However, procoagulants must strike the right balance between stopping bleeding and preventing excessive clotting, as occurs in conditions such as deep vein thrombosis or when a blood clot causes a stoke.
Just as with inflammation, a little coagulation is good, but too much is dangerous, Griffin says. While a small amount of cardiac myosin might help reduce bleeding in the heart, an excess of the protein may worsen the injury by promoting blood clots that cut off oxygen and exacerbate damage to heart tissue.
Indeed, Griffin and his collaborators, including Tobias Eckle, MD, PhD, of the University of Colorado, found that excess cardiac myosin doubled heart damage when administered to mice who experienced controlled heart attacks.
The study appears in the April 2020 issue of the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology.
Griffin and his team are now working with scientists at Calibr, the drug discovery and development division of Scripps Research, to create a therapeutic compound that would target the procoagulant activity of cardiac myosin, reducing tissue damage caused by a heart attack.
Anticoagulant drugs already exist, ranging from over-the-counter medications like aspirin to widely prescribed drugs such as coumadin and warfarin. A newer class of drugs, known as direct oral anticoagulants (commonly referred to as DOACs), also have emerged to address the great need for blood clotting medications. But many of these existing drugs can cause excessive bleeding or other side effects because they act on the entire body's coagulation system, not just blood clotting in the heart.
Griffin envisions an anticoagulant medicine that targets only cardiac myosin-driven coagulation. Such a drug could theoretically be administered to patients in the hospital immediately after an acute cardiac event.
Cardiovascular disease is the leading cause of death for men, women and people of most racial and ethnic groups in the United States, Griffin says. New and better medicines are needed for those at risk of disease, and cardiac myosin gives us a promising avenue to pursue.
Authors of the study, Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo, include Jevgenia Zilberman-Rudenko, Hiroshi Deguchi, Meenal Shukla, Yoshimasa Oyama, Jennifer N. Orje, Zihan Guo, Tine Wyseure, Laurent O. Mosnier, Owen J.T. McCarty, Zaverio M. Ruggeri, Tobias Eckle and John H. Griffin.
The work was supported by the American Heart Association and multiple grants from the National Institutes of Health.
Heart Disease Griffin, John
North America Stories
07/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/04/2026
Frequency, the engine behind many of the world's leading streaming television channels, at NAB 2026 will be launching new Studio services to help content ow...
07/04/2026
Ikegami USA has chosen NAB 2026 in Las Vegas as the launch platform for new additions to its range of broadcast-quality television production equipment. These w...
07/04/2026
April 19, 2026, Las Vegas Kiloview, an innovative provider of AV-over-IP technologies, will showcase its latest broadcast IP solutions at NAB 2026, presenting...
07/04/2026
Bitmovin has announced support for Server-Guided Ad Insertion (SGAI) across its playback products using HLS interstitials, enabling more advanced ad-supported s...
07/04/2026
Synamedia is unveiling AI by Quortex at The NAB show, a just-in-time AI plugin framework that applies intelligence only when needed across video processing, dis...
07/04/2026
Cuez will showcase four additions to its cloud-based newsroom, rundown and automation platform at NAB Show 2026 (April 18 22, Las Vegas, Booth N1867):
Cuez ...
07/04/2026
CueScript to Showcase Innovations at NAB that Add Mobility Options, Ease Editing...
07/04/2026
Barix Extends Transport Options for Multi-Engine IP Encoder
Brie Clayton April 7, 2026
0 Comments
New for NAB, Barix adds SRT and RIST support to Mult...
07/04/2026
Elite Media Technologies Selects Interra Systems' BATON File-Based QC Soluti...
07/04/2026
Tightrope Media Systems to Debut Cablecast LiveBridge for Simultaneous Streaming...
07/04/2026
Cuez Brings Four New Innovations to NAB 2026: From Story-Centric Newsroom to Ope...
07/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/04/2026
Designed for synchronized multi-stream playback, low-latency delivery, and real-time analytics, MATCH introduces a unified viewing experience for sports broadca...
07/04/2026
Berklee Students to Honor George Martin with Performance of Original Scores The orchestra, led by associate professor Xander Rovang, will perform several work...
06/04/2026
Michigan legends bring a new voice to the broadcast as TNT Sports and CBS Sports...
06/04/2026
From high school sports all the way up to the major leagues, building high-quali...
06/04/2026
Quickplay, an AI company for the media and entertainment industry, has been accepted into the Advanced tier of the TwelveLabs Ecosystem Partner Program. Quickpl...
06/04/2026
Grass Valley has announced the Future Playmakers Program, a global initiative to...
06/04/2026
El l der de operaciones impulsa la producci n en estudio mientras encuentra insp...
06/04/2026
The ops leader helps lead the charge in studio for the Spanish-language broadcas...
06/04/2026
Behind The Mic provides a roundup of recent news regarding on-air talent, includ...
06/04/2026
The National Hockey League (NHL), in partnership with Verizon and the New Jersey Devils, today announced the opening of the NHL Innovation Lab powered by Verizo...
06/04/2026
Rock League, a new professional curling league, has announced that ESPN+ will stream its inaugural 2026 season for fans in the United States. The first Rock Lea...
06/04/2026
Advanced Systems Group has announced the appointment of Andrea (Andy) Cummis as Vice President of Systems Design and Engineering. In this role, she will lead de...
06/04/2026
Backed by Bolt Ventures, the venture brings Bryson DeChambeau, Grant Horvat, and...
06/04/2026
With this environment we can start that collaboration even earlier because we ca...
06/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
06/04/2026
Dalet Showcases Dalia Agentic AI and End-to-End Media Workflows at NAB Show 2026
Brie Clayton April 6, 2026
0 Comments
Dalet, a leading technology and...
06/04/2026
OpenDrives Shows Off Sports Expertise in Sports Business Hub located in NAB Show...
06/04/2026
Proton to Demonstrate 3D Application at NAB 2026
Brie Clayton April 6, 2026
0 Comments
Yet further creative potential unleashed through innovation in ...
06/04/2026
Autoscript Highlights Voice-Driven Prompting and PTZ Solutions at NAB 2026
Brie Clayton April 6, 2026
0 Comments
Experience Autoscript Voice, PTZ prom...
06/04/2026
Mediaproxy Highlights Significant Enhancements to its LogServer suite at NAB Sho...
06/04/2026
April 6th, 2026
TRIBECA STUDIOS AND LILLY ANNOUNCE WINNERS OF INAUGURAL VITAL...
06/04/2026
Back to All News
Netflix Expands Kids Entertainment Lineup With Playground App ...
04/04/2026
The University of Arizona's Men's Basketball team has only loss twice th...
04/04/2026
1080p HDR arrives, a new generation of storytelling tools takes center stage, an...
04/04/2026
Michigan legends bring a new voice to the broadcast as TNT Sports and CBS Sports...
04/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/04/2026
DHD Introduces AI-Based Audio Noise Reduction to XD3 IP Core
Brie Clayton April 3, 2026
0 Comments
The accompanying image shows the rear panel of the ...
04/04/2026
Macnica Redefines ST 2110 Flexibility with Two Speeds on One Card
Brie Clayton April 3, 2026
0 Comments
New for NAB Show 2026, MEP100 SmartNIC now sup...
04/04/2026
Unified Media Workflows for Story-Centric Production
Brie Clayton April 3, 2026
0 Comments
Framelight X unifies field capture, editing and publishing ...
Muscle protein abundant in the heart plays key role in blood clotting during heart attack The surprise finding from a Scripps Research team reveals a potential new approach for treating cardiovascular diseases.
